Skip to main content

Recombinant Human HSPB7, N-His

Reference: ARO-P13036
Size

100ug

Brand

Arovia

Product type

Recombinant Proteins

Product nameRecombinant Human HSPB7, N-His
Origin speciesHuman
Expression systemProkaryotic expression
Molecular weight20.92 kDa
BufferLyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
FormLiquid
Delivery conditionDry Ice
Delivery lead time in business days3-5 days if in stock; 3-5 weeks if production needed
Storage condition4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
BrandArovia
Host speciesEscherichia coli (E.coli)
Fragment TypeMet1-Ile170
Aliases /SynonymsHSPB7, CVHSP, Cardiovascular heat shock protein, cvHsp, HspB7, Heat shock protein beta-7
ReferenceARO-P13036
NoteFor research use only.

Description of Recombinant Human HSPB7, N-His

Introduction

Recombinant Human HSPB7, also known as heat shock protein beta-7, is a protein that plays an important role in cellular stress response and protection against various diseases. This protein is produced through recombinant DNA technology, making it a valuable tool in scientific research and potential therapeutic applications.

Structure of Recombinant Human HSPB7

Recombinant Human HSPB7 is a small protein consisting of 209 amino acids with a molecular weight of approximately 22 kDa. It belongs to the family of small heat shock proteins (sHSPs) and is highly conserved across different species. The protein has a characteristic α-crystallin domain, which is responsible for its chaperone activity.

Activity of Recombinant Human HSPB7

Recombinant Human HSPB7 is primarily involved in protecting cells from stress-induced damage. It acts as a molecular chaperone, which means it helps other proteins to fold correctly and prevents them from aggregating under stressful conditions. This chaperone activity is crucial for the proper functioning of cells, as misfolded proteins can lead to various diseases, including neurodegenerative disorders.

In addition to its chaperone activity, Recombinant Human HSPB7 has been shown to have anti-apoptotic properties, meaning it can prevent cells from undergoing programmed cell death. This activity is particularly important in protecting cells from damage caused by oxidative stress, which is a major contributor to various diseases, including cancer and cardiovascular diseases.

Application of Recombinant Human HSPB7

Recombinant Human HSPB7 has a wide range of potential applications in both scientific research and therapeutic interventions. Some of the key applications are listed below:

1. Recombinant Protein Production

Recombinant Human HSPB7 can be produced in large quantities using recombinant DNA technology. This makes it a valuable tool for studying the structure and function of the protein, as well as its role in cellular stress response. Recombinant Human HSPB7 can also be used as a control protein in experiments involving other heat shock proteins.

2. Biomarker for Disease Diagnosis

There is growing evidence that levels of HSPB7 are altered in various diseases, including heart failure and neurodegenerative disorders. Recombinant Human HSPB7 can be used as a biomarker to detect these diseases at an early stage and monitor their progression. This can aid in timely diagnosis and treatment, improving patient outcomes.

3. Potential Therapeutic Applications

Given its anti-apoptotic and chaperone activities, Recombinant Human HSPB7 has the potential to be developed as a therapeutic agent for various diseases. For example, it could be used to protect cells from damage during chemotherapy or as a treatment for neurodegenerative disorders. Further research is needed to explore these potential therapeutic applications.

4. Vaccine Development

Recombinant Human HSPB7 can also be used in vaccine development as an antigen. Antigens are substances that stimulate the body’s immune system to produce antibodies, which can then protect against specific diseases. By using Recombinant Human HSPB7 as an antigen, researchers can potentially develop vaccines against diseases that are associated with this protein, such as heart failure.

Conclusion

In summary, Recombinant Human HSPB7 is a valuable protein with various potential applications in scientific research and therapeutic interventions. Its structure, activity, and potential applications make it a promising target for further study and development. With continued research, this protein has the potential to improve our understanding of cellular stress response and provide new treatments for various diseases.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Recombinant Human HSPB7, N-His”

Your email address will not be published. Required fields are marked *

Related products

Anti His tag mouse monoclonal antibody
Tag Antibody

Anti His tag mouse monoclonal antibody

PTX17851 214$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products